Skip to main content
Premium Trial:

Request an Annual Quote

Agilent IQFISH Lung Cancer Panel

Agilent Technologies has launched its IQFISH lung cancer panel for automated analysis on Dako Omnis in Europe with a CE-IVD mark. The panel comprises ALK, ROS1, RET, and MET IQFISH probes, andwas designed using oligonucleotide-based SureFISH technology with formamide-free IQFISH fast hybridization buffer. The panel allows labs to simultaneously stain IHC and FISH slides and enable multiple FISH slides to be processed in just four hours, the company said.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.